Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Merrimack Pharmaceuticals Inc (MACK)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Newtyn Management

Noah Levy And Eugene Dozortsev

1,212,144 $7,333 +6% 0.94%
2.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

647,635 $3,918 0.12%
3.
Millennium Management

Israel Englander

0 $0 0%
4. 13,459 $82 0%
5.
D E Shaw

D. E. Shaw

19,587 $119 -82% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$5.44 302 Large Shareholder, Other 3,802 2019-07-16 Filing
$5.62 1,000 Large Shareholder, Other 3,500 2019-07-12 Filing
$5.71 2,400 Large Shareholder, Other 2,500 2019-07-12 Filing
$5.71 100 Large Shareholder, Other 100 2019-07-11 Filing
$5.85 10,107 Large Shareholder, Other 739,676 2019-07-02 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$14.23 7,796 Director 22,681 2017-09-15 Filing
$14.20 100 Director 22,681 2017-09-14 Filing
$14.27 6,800 Director 22,681 2017-09-13 Filing
$14.46 14,756 Director 22,681 2017-09-11 Filing
$3.72 4,097 Officer 101,731 2017-05-12 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 9,000 $40 0%
2. 500 $2 0%
3. 3,055 $14 0%
News See All